Abstract
The world is currently facing an unprecedented global pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Predicting the next source of the pandemic can be very challenging. As vaccination is the best way to prevent an infectious disease, the development of an effective vaccine against SARS-CoV-2 can not only reduce the morbidity and mortality associated with it, but can also lessen the economic impact. As the traditional method of vaccine development takes many years for a vaccine to be available to the society, the vaccine development for SARS-CoV-2 should be speeded up using a pandemic approach with fast-track approvals from the regulatory authorities. Various challenges associated with developing a vaccine during the pandemic such as technological hurdles, clinical development pathways, regulatory issues, and support from global funding agencies are expressed here.
Keywords: COVID-19, Immunization, Pandemic, Prevention, SARS-CoV-2
Acknowledgements
Shashi Kanth Muni (Associate Medical Director, Bharat Biotech) and Dr. Sapan Kumar Behera (Senior Manager, Bharat Biotech) supported the preparation of this manuscript.
Footnotes
Competing interests: KME is Chairman and Managing Director and VKM is Executive Director of Bharat Biotech International Limited, which is a vaccine manufacturer
References
- 1.Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–74. doi: 10.1016/S0140-6736(20)30251-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. BioRxiv. 2020. Severe acute respiratory syndromerelated coronavirus: the species and its viruses–a statement of the coronavirus study group. [Google Scholar]
- 4.Wan Y, Shang J, Graham R, Baric RS, Li F. J Virol. 2020. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. N Engl J Med. 2020. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19) 2020. [PubMed] [Google Scholar]
- 7.WHO 2018 Annual review of diseases prioritized under the Research and Development Blueprint. https://www.who.int/blueprint/priority-diseases/key-action/novel-coronaviruslandscape-ncov.pdf. Accessed April 11, 2020.
- 8.Zhang J, Zeng H, Gu J, Li H, Zheng L, Zou Q. Progress and prospects on vaccine development against SARS-CoV-2. Vaccines (Basel) 2020;8:153. doi: 10.3390/vaccines8020153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lurie N, Saville M, Hatchett R, Halton J. N Engl J Med. 2020. Developing Covid-19 vaccines at pandemic speed. [DOI] [PubMed] [Google Scholar]
- 10.Yamey G, Schäferhoff M, Hatchett R, Pate M, Zhao M, McDade KK. Lancet. 2020. Ensuring global access to COVID-19 vaccines. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Le TT, Andreadakis Z, Kumar A, Román RG, Tollefsen S. Nature Rev Drug Disc. 2020. The COVID-19 vaccine development landscape. [DOI] [PubMed] [Google Scholar]
- 12.Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP. Hum Vaccin Immunother. 2020. COVID-19, an emerging coronavirus infection: Advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Global Alliance for Vaccines and Immunisation (Gavi.org) Media room. Available from: https://www.gavi.org/news/media-room/gavi-board-calls-bold-engagement-respondcovid-19. Accessed April 12, 2020.
- 14.Fedson DS. Vaccine development for an imminent pandemic: Why we should worry, what we must do. Human Vacc. 2006;2:38–42. doi: 10.4161/hv.2.1.2554. [DOI] [PubMed] [Google Scholar]